Is S8V undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of S8V when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: S8V (€37.2) is trading above our estimate of fair value (€32.17)
Significantly Below Fair Value: S8V is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for S8V?
Key metric: As S8V is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for S8V. This is calculated by dividing S8V's market cap by their current
earnings.
What is S8V's PE Ratio?
PE Ratio
9.4x
Earnings
€405.64m
Market Cap
€3.80b
S8V key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: S8V is good value based on its Price-To-Earnings Ratio (9.4x) compared to the Global Specialized REITs industry average (19.2x).
Price to Earnings Ratio vs Fair Ratio
What is S8V's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
S8V PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
9.4x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate S8V's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst S8V forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€37.20
€47.11
+26.6%
11.0%
€56.00
€35.00
n/a
14
Nov ’25
€37.15
€47.04
+26.6%
10.8%
€55.00
€35.00
n/a
14
Oct ’25
€40.45
€47.04
+16.3%
11.3%
€55.00
€35.00
n/a
13
Sep ’25
€37.80
€46.76
+23.7%
11.8%
€55.00
€35.00
n/a
13
Aug ’25
€34.80
€45.99
+32.2%
11.4%
€54.00
€35.00
n/a
12
Jul ’25
€33.70
€46.04
+36.6%
11.3%
€54.00
€35.00
n/a
12
Jun ’25
€38.65
€46.50
+20.3%
11.3%
€54.00
€35.00
n/a
13
May ’25
€36.65
€46.65
+27.3%
11.1%
€54.00
€35.00
n/a
13
Apr ’25
€39.02
€47.28
+21.2%
11.9%
€58.00
€35.00
n/a
13
Mar ’25
€38.00
€46.79
+23.1%
12.9%
€58.00
€34.00
n/a
14
Feb ’25
€41.24
€45.92
+11.4%
11.7%
€53.00
€34.00
n/a
13
Jan ’25
€42.90
€43.42
+1.2%
14.1%
€53.00
€30.00
n/a
13
Dec ’24
€38.00
€43.27
+13.9%
14.0%
€53.00
€30.00
n/a
13
Nov ’24
€33.72
€46.12
+36.8%
13.2%
€58.00
€37.00
€37.15
13
Oct ’24
€35.80
€46.11
+28.8%
12.7%
€58.00
€37.00
€40.45
14
Sep ’24
€39.04
€46.81
+19.9%
13.3%
€58.00
€37.00
€37.80
13
Aug ’24
€39.30
€47.05
+19.7%
10.9%
€53.00
€37.00
€34.80
11
Jul ’24
€41.64
€47.14
+13.2%
11.0%
€53.00
€37.00
€33.70
11
Jun ’24
€41.04
€47.14
+14.9%
11.0%
€53.00
€37.00
€38.65
11
May ’24
€43.70
€46.65
+6.8%
11.5%
€53.00
€37.00
€36.65
10
Apr ’24
€44.20
€46.40
+5.0%
11.0%
€53.00
€37.00
€39.02
10
Mar ’24
€43.50
€46.60
+7.1%
11.4%
€53.00
€37.00
€38.00
10
Feb ’24
€42.50
€46.10
+8.5%
11.1%
€53.00
€37.00
€41.24
10
Jan ’24
€41.75
€48.55
+16.3%
7.8%
€53.00
€41.00
€42.90
10
Dec ’23
€40.85
€49.41
+21.0%
9.1%
€58.00
€41.00
€38.00
11
Nov ’23
€42.50
€49.41
+16.3%
9.1%
€58.00
€41.00
€33.72
11
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.